medpace-logo

Download the Article

Discover strategies for optimizing age-related macular degeneration (AMD) trial design through integrated imaging, protocol development, and patient recruitment approaches.

Ophthalmology Article - HubSpot Background (72ppi)

Trust Medpace to Accelerate Your Next AMD Clinical Trial

Your article is ready for download.

With continuing innovations and advances in ophthalmology, AMD clinical trials are becoming increasingly more frequent and complex. These trials require a CRO partner with innovative patient enrollment capabilities, strong relationships with top-performing sites, strategic study design and execution, and cell, gene and RNA based therapy experience.

Click the "Read Now" button below to access your copy of our comprehensive AMD article "Advancing Vision: Trends and Breakthroughs in the Wet & Dry AMD Clinical Trial Landscape".

Read Now
AMD Article
Ophthalmology

Advancing AMD Through Integrated Clinical Development

With extensive Phase II-IV ophthalmology experience and integrated imaging capabilities, Medpace accelerates the development of therapeutics for both wet and dry AMD. Our ophthalmology-focused teams include medical experts, clinical operations specialists, and regulatory professionals who understand the complexities of AMD trial design, endpoint selection, and regulatory pathways for FDA and EMA submissions. 

Contact our experts to learn how we can assist your next ophthalmology study.

Explore Our Ophthalmology Capabilities
Ophthamology Icon - Navy